KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) FCF Margin: 2018-2025

Historic FCF Margin for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to 60.41%.

  • Aurinia Pharmaceuticals' FCF Margin rose 3541.00% to 60.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 45.10%, marking a year-over-year increase of 3236.00%. This contributed to the annual value of 18.76% for FY2024, which is 3823.00% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' FCF Margin stood at 60.41%, which was down 4.19% from 63.05% recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' FCF Margin peaked at 63.05% during Q2 2025, and registered a low of -5,971.55% during Q1 2021.
  • Over the past 3 years, Aurinia Pharmaceuticals' median FCF Margin value was 25.00% (recorded in 2024), while the average stood at 8.89%.
  • Data for Aurinia Pharmaceuticals' FCF Margin shows a peak YoY increase of 11,678,656bps (in 2021) and a maximum YoY decrease of 11,402bps (in 2021) over the last 5 years.
  • Over the past 5 years, Aurinia Pharmaceuticals' FCF Margin (Quarterly) stood at -110.76% in 2021, then spiked by 14,704bps to 36.28% in 2022, then plummeted by 520bps to 31.07% in 2023, then surged by 1,913bps to 50.21% in 2024, then skyrocketed by 3,541bps to 60.41% in 2025.
  • Its FCF Margin was 60.41% in Q3 2025, compared to 63.05% in Q2 2025 and 2.05% in Q1 2025.